Literature DB >> 8661007

Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships.

R Opavský1, S Pastoreková, V Zelník, A Gibadulinová, E J Stanbridge, J Závada, R Kettmann, J Pastorek.   

Abstract

We have isolated, sequenced, and characterized a human MN/CA9 gene. This gene is a novel member of the carbonic anhydrase (CA) family, which codes for widely distributed catalysts of the reversible conversion of carbon dioxide to carbonic acid. So far, MN/CA IX is the only tumor-associated CA isoenzyme. The entire genomic sequence of MN/CA9, including the 5'-flanking region, encompasses 10.9 kb. The coding sequence is divided into 11 exons, whose organization and relationships to predicted protein domains suggest that the gene arose by exon shuffling. Exon 1 encodes a signal peptide and a proteoglycan-related region. Exons 2-8 code for a CA domain with a highly conserved active site. The exon/intron pattern of the CA coding region is similar but not identical to other described animal kingdom alpha-CA genes. Exons 10 and 11 encode a transmembrane anchor and an intracytoplasmic tail, respectively. We have also determined the transcription initiation and termination sites by RNase protection assay and analyzed the 3. 5-kb region upstream of the MN/CA9 gene. Sequence of the proximate 5' end of the flanking region shows extensive homology to the long terminal repeats of HERV-K endogenous retroviruses. The putative MN/CA9 promoter immediately preceding the transcription start site does not possess a TATA box, but contains consensus sequences for the AP1, AP2, p53, and Inr transcription factors. This study will allow further investigations of the molecular events regulating expression of MN/CA IX as well as elucidation of its biological function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661007     DOI: 10.1006/geno.1996.0223

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  107 in total

1.  Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells.

Authors:  Ying Li; Hai Wang; Chingkuang Tu; Kathleen T Shiverick; David N Silverman; Susan C Frost
Journal:  Biochim Biophys Acta       Date:  2010-10-12

Review 2.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

Review 3.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors:  Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal:  Biochim Biophys Acta       Date:  2009-01-22

Review 4.  G250: a carbonic anhydrase IX monoclonal antibody.

Authors:  John S Lam; Allan J Pantuck; Arie S Belldegrun; Robert A Figlin
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

5.  Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer.

Authors:  Joo-Young Kim; Hye-Jin Shin; Tae-Hyun Kim; Kwan-Ho Cho; Kyung-Hwan Shin; Bu-Kyoung Kim; Ju-Won Roh; Sun Lee; Sang-Yoon Park; You-Jin Hwang; Inn-Oc Han
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-14       Impact factor: 4.553

Review 6.  Novel approaches in the therapy of metastatic renal cell carcinoma.

Authors:  John S Lam; John T Leppert; Arie S Belldegrun; Robert A Figlin
Journal:  World J Urol       Date:  2005-04-05       Impact factor: 4.226

7.  The role of carbonic anhydrases in tumors.

Authors:  A Nógrádi
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

8.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

9.  Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma.

Authors:  Martina Takacova; Maria Bartosova; Lucia Skvarkova; Miriam Zatovicova; Ivana Vidlickova; Lucia Csaderova; Monika Barathova; Jan Breza; Peter Bujdak; Jaromir Pastorek; Jan Breza; Silvia Pastorekova
Journal:  Oncol Lett       Date:  2012-10-26       Impact factor: 2.967

Review 10.  Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain.

Authors:  Emma Langella; Martina Buonanno; Giuseppina De Simone; Simona Maria Monti
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.